The Enterprise Value as of December 2024 (TTM) for Miromatrix Medical Inc. (MIRO) is 90.06M

According to Miromatrix Medical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 90.06M. This represents a change of 114.64% compared to the average of 41.96M of the last 4 quarters.

Miromatrix Medical Inc. (MIRO) Historical Enterprise Value (quarterly & annually)

How has MIRO Enterprise Value performed in the past?

The mean historical Enterprise Value of Miromatrix Medical Inc. over the last ten years is 95.95M. The current 90.06M Enterprise Value has changed 9.29% with respect to the historical average. Over the past ten years (40 quarters), MIRO's Enterprise Value was at its highest in in the March 2021 quarter at 273.37M. The Enterprise Value was at its lowest in in the June 2021 quarter at -31716014.30.

Miromatrix Medical Inc. (MIRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Miromatrix Medical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Miromatrix Medical Inc. (MIRO) Average Enterprise Value

How has MIRO Enterprise Value performed in the past?

The current Enterprise Value of Miromatrix Medical Inc. (MIRO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Miromatrix Medical Inc. (MIRO) Enterprise Value vs. Peers

How is MIRO’s Enterprise Value compared to its peers?

Miromatrix Medical Inc.’s Enterprise Value is greater than Anebulo Pharmaceuticals, Inc. (37.88M), greater than PMV Pharmaceuticals, Inc. (40.27M), greater than ZIVO Bioscience, Inc. (78.24M), less than Bionomics Limited (1.26B), less than Molecular Partners AG (107.67M), less than Mineralys Therapeutics, Inc. (521.35M), greater than AN2 Therapeutics, Inc. (6.98M), less than Pharvaris N.V. (675.03M), less than PepGen Inc. (106.16M), less than NervGen Pharma Corp. (197.08M), less than Acrivon Therapeutics, Inc. Common Stock (152.40M), greater than Protagenic Therapeutics, Inc. (2.14M), less than Inhibikase Therapeutics, Inc. (200.81M), less than Eliem Therapeutics, Inc. (0), greater than HCW Biologics Inc. (26.93M),

Build a custom stock screener for Miromatrix Medical Inc. (MIRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Miromatrix Medical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Miromatrix Medical Inc. (MIRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Miromatrix Medical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.